Harrington AM - Search Results

1

Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer.

Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Harrington AM, Shields PG, Felley-Bosco E, Hussain SP, Harris CC. Ambs S, et al. Among authors: harrington am. J Natl Cancer Inst. 1999 Jan 6;91(1):86-8. doi: 10.1093/jnci/91.1.86. J Natl Cancer Inst. 1999. PMID: 9890175 Free article. No abstract available.

2

Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.

Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Kato S, et al. Among authors: harrington am. J Natl Cancer Inst. 1995 Jun 21;87(12):902-7. doi: 10.1093/jnci/87.12.902. J Natl Cancer Inst. 1995. PMID: 7666479

3

Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.

Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A. Shields PG, et al. Among authors: harrington am. Cancer Res. 1993 Aug 1;53(15):3486-92. Cancer Res. 1993. PMID: 8339251

4

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

Trivers GE, De Benedetti VM, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, Miller RD, Harris CC. Trivers GE, et al. Among authors: harrington am. Clin Cancer Res. 1996 Oct;2(10):1767-75. Clin Cancer Res. 1996. PMID: 9816128

5

The impact of glutathione s-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans.

Rothman N, Shields PG, Poirier MC, Harrington AM, Ford DP, Strickland PT. Rothman N, et al. Among authors: harrington am. Mol Carcinog. 1995 Sep;14(1):63-8. doi: 10.1002/mc.2940140111. Mol Carcinog. 1995. PMID: 7546226

6

A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.

Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, Marshall JR, Vena JE, Laughlin R, Nemoto T, Freudenheim JL. Shields PG, et al. Among authors: harrington am. Mol Carcinog. 1996 Nov;17(3):144-50. doi: 10.1002/(SICI)1098-2744(199611)17:3<144::AID-MC6>3.0.CO;2-F. Mol Carcinog. 1996. PMID: 8944074

7

Molecular epidemiology of lung and breast cancer.

Ambrosone CB, Kato S, Bowman ED, Harrington AM, Blomeke B, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Shields PG. Ambrosone CB, et al. Among authors: harrington am. Eur J Cancer Prev. 1996 Oct;5(5):391-2. Eur J Cancer Prev. 1996. PMID: 8972270 Review. No abstract available.

8

Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens.

Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G, et al. Vineis P, et al. Among authors: harrington am. Nature. 1994 May 12;369(6476):154-6. doi: 10.1038/369154a0. Nature. 1994. PMID: 7909916

9

Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk.

Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A, et al. Ambrosone CB, et al. Among authors: harrington a. Cancer Res. 1995 Aug 15;55(16):3483-5. Cancer Res. 1995. PMID: 7627950

10

Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review.

Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM. Ronen S, et al. Among authors: harrington am. Int J Lab Hematol. 2019 Feb;41(1):69-79. doi: 10.1111/ijlh.12924. Epub 2018 Sep 14. Int J Lab Hematol. 2019. PMID: 30216684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page